T
LIVE

Serial Number

98585319

Owner

T-Therapeutics Limited

Attorney

Stacy J. Grossman

Filing Date

Jun 5, 2024

Add to watchlist:

No watchlists yet
View on USPTO

T Trademark

Serial Number: 98585319 • Registration: 7774607

T is a trademark filed by T-Therapeutics Limited on June 5, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 31 (Natural Agricultural Products). The application is currently registered and active.

Owner Contact Info

T-Therapeutics Limited (7 trademarks)

Abington Hall, Granta Park
Cambridge CB216AL , GB

Entity Type: 99

Trademark Details

Filing Date

June 5, 2024

Registration Date

April 29, 2025

Published for Opposition

March 11, 2025

Goods & Services

Downloadable computer software for use in collecting, analyzing and organizing data in the field of pharmaceuticals, biopharmaceutical drug development and genome engineering; downloadable computer software for use in collecting, analyzing and organizing data in the field of scientific and pharmaceutical research and development; downloadable software for scientific modelling of pharmaceuticals in the field of scientific and pharmaceutical research and development; downloadable software for pharmaceutical modelling in the field of scientific and pharmaceutical research and development; downloadable software for research and development in the field of antibodies; devices for analyzing genome information, namely, laboratory devices for detecting genetic sequences; downloadable software for performing gene sequencing research and visualization, namely, scientific analysis of genetic sequences; downloadable software for the managing, analysis, and visualization of biological data

Pharmaceutical preparations for the treatment of, protection from and prevention of viral and bacterial infections, cancer, inflammation, autoimmune diseases and infectious diseases; chemical and biological pharmaceutical preparations for medical purposes for the treatment of, protection from and prevention of viral and bacterial infections, cancer, inflammation, autoimmune diseases and infectious diseases; biological preparations for the treatment of cancer; biological preparations for the treatment of viral infections; biological preparations for the treatment of autoimmune diseases; biological preparations for medical use namely, for the treatment of, protection from and prevention of viral and bacterial infections, cancer, inflammation, autoimmune diseases and infectious diseases; immunotherapeutic drugs namely, for the treatment of, protection from and prevention of viral and bacterial infections, cancer, inflammation, autoimmune diseases and infectious diseases; reagents for medical use; diagnostic preparations for medical purposes; diagnostic reagents for medical use; preparations for detecting genetic predispositions for medical purposes; living cells for medical use; biological preparations for use in cell cultures for medical purposes, namely for T-cell therapy, gene therapy and cell therapy; biological and pharmaceutical preparations in the form of living cells for medical use in the treatment of immunological diseases; T-cell therapy pharmaceutical preparations for the treatment of, protection from and prevention of viral and bacterial infections, cancer, inflammation, autoimmune diseases and infectious diseases; pharmaceutical preparations in the nature of genetically modified immune cells for the treatment of cancer

Medical services; Medical services, namely providing medical diagnostic and prognostic services; veterinary services; medical analysis services relating to the treatment of persons; pharmaceutical advice; medical and health care services relating to DNA, genetics, and genetic pathogen testing for diagnostic or treatment purposes; medical screening and assaying in the nature of medical laboratory analysis services relating to the treatment of persons; DNA screening for medical purposes; mice breeding services; medical services relating to the removal, treatment and processing of living human cells; medical services, namely treatment and preparation of living immune cells for medical use; immune cell therapy medical treatment services; medical testing for diagnostic or treatment purposes in the field of cell therapy and gene therapy; medical analysis for diagnostic and treatment purposes and medical consulting in connection with immunotherapy; DNA analysis services in the field of DNA sequencing for diagnostic and treatment purposes

Scientific, medical and technological services, namely, scientific research and development in the field of pharmaceuticals for genome engineering and biopharmaceutical drug development for the treatment of, protection from and prevention of infections, cancer, disease, inflammation and autoimmune diseases; design and development of computer hardware and software; platform as a service (PAAS) featuring computer software platforms for use in database management in the field of pharmaceuticals, biopharmaceutical drug development and genome engineering; Platform as a service (PAAS) featuring computer software platforms for DNA analysis; Platform as a service (PAAS) featuring computer software platforms for use in DNA sequencing; software as a service (SAAS) services featuring software for analyzing DNA; software as a service (SAAS) services featuring software for use in database management in the field of pharmaceuticals, biopharmaceutical drug development and genome engineering; Providing temporary use of online non-downloadable software for the management, visualization and analysis of biological data for the purposes of biomolecular research and the design and engineering of biomolecular products; DNA analysis services in the field of DNA sequencing for scientific research purposes; provision of a web hosting platform for the analysis of DNA sequencing data for scientific research purposes and diagnostic and treatment purposes; biomedical research services in relation to developing transgenic mice; Biomedical research services, namely, preparation of biological samples in the nature of living cells for analysis and research purposes; Biological analysis, namely structural and functional analysis of genomes for cell therapy and gene therapy; drug discovery services in the field of cell therapy and gene therapy; pharmaceutical drug development services, namely, development of gene based medicines and therapies; pharmaceutical drug development services, namely, development of pharmaceutical and medical preparations and medicines in the field of cell therapy and gene therapy; research in the field of gene therapy and cell therapy

Live laboratory mice, namely, live transgenic mice

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 29, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 29, 2025 R.PR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 28, 2025 TCCA
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 5, 2025 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 18, 2025 PREV
ASSIGNED TO LIE
Feb 18, 2025 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 13, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 13, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 13, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 13, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 13, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 13, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 13, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 13, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 18, 2024 GNRN
NON-FINAL ACTION E-MAILED
Dec 18, 2024 GNRT
NON-FINAL ACTION WRITTEN
Dec 18, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 18, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Dec 17, 2024 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 17, 2024 NWOS
NEW APPLICATION ENTERED
Jun 5, 2024 NWAP